Market Overview

UPDATE: Pfizer Posts Upbeat Q4 Results

Share:
Related PFE
In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
Here Are All The Big Biotech Mergers In 2016
Biotech Forum Daily Digest: Mylan Adjusts Course, Who Is Next Midcap Buyout Target After Medivation? Spotlight On NeuroDerm (Seeking Alpha)

Pfizer (NYSE: PFE) reported a rise in its fourth-quarter profit.

Pfizer's quarterly profit surged to $6.3 billion, or $0.85 per share, versus $1.4 billion, or $0.19 per share, in the year-earlier period. Its adjusted profit came in at $0.47 per share.

Its revenue dropped 7% to $15.07 billion. However, analysts were expecting earnings of $0.44 per share on revenue of $14.4 billion.

Pfizer projects 2013 adjusted profit of $2.20 to $2.30 per share, versus analysts' estimates of $2.28 per share.

Pfizer shares rose 0.52% to $26.98 in pre-market trading.

Posted-In: profitEarnings News Guidance

 

Related Articles (PFE)

View Comments and Join the Discussion!